MAPT and Alzheimer disease: This study suggest not only that future inhibitors should target common interface region of Aβ and Tau but also that the determination of the high-resolution structure of Aβ-Tau complex would contribute to the understanding of the key binding residues for optimized inhibition of amyloid seeding in AD.